These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 25435150)
1. Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators. Han C; Chatterjee A; Noetzel MJ; Panarese JD; Smith E; Chase P; Hodder P; Niswender C; Conn PJ; Lindsley CW; Stauffer SR Bioorg Med Chem Lett; 2015 Jan; 25(2):384-8. PubMed ID: 25435150 [TBL] [Abstract][Full Text] [Related]
2. SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs). Kuduk SD; Beshore DC Curr Top Med Chem; 2014; 14(15):1738-54. PubMed ID: 25176125 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor. Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562 [TBL] [Abstract][Full Text] [Related]
4. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor. Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor. Abdul-Ridha A; Lane JR; Mistry SN; López L; Sexton PM; Scammells PJ; Christopoulos A; Canals M J Biol Chem; 2014 Nov; 289(48):33701-11. PubMed ID: 25326383 [TBL] [Abstract][Full Text] [Related]
6. Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor. Flohr A; Hutter R; Mueller B; Bohnert C; Pellisson M; Schaffhauser H Bioorg Med Chem Lett; 2017 Dec; 27(24):5415-5419. PubMed ID: 29146472 [TBL] [Abstract][Full Text] [Related]
7. Fused heterocyclic M1 positive allosteric modulators. Kuduk SD; Di Marco CN; Cofre V; Ray WJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT Bioorg Med Chem Lett; 2011 May; 21(9):2769-72. PubMed ID: 21055928 [TBL] [Abstract][Full Text] [Related]
8. Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior. Choy KH; Shackleford DM; Malone DT; Mistry SN; Patil RT; Scammells PJ; Langmead CJ; Pantelis C; Sexton PM; Lane JR; Christopoulos A J Pharmacol Exp Ther; 2016 Nov; 359(2):354-365. PubMed ID: 27630144 [TBL] [Abstract][Full Text] [Related]
9. The existence of a second allosteric site on the M1 muscarinic acetylcholine receptor and its implications for drug design. Espinoza-Fonseca LM; Trujillo-Ferrara JG Bioorg Med Chem Lett; 2006 Mar; 16(5):1217-20. PubMed ID: 16364641 [TBL] [Abstract][Full Text] [Related]
10. 6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M Jörg M; van der Westhuizen ET; Khajehali E; Burger WAC; White JM; Choy KHC; Tobin AB; Sexton PM; Valant C; Capuano B; Christopoulos A; Scammells PJ ACS Chem Neurosci; 2019 Mar; 10(3):1099-1114. PubMed ID: 30547573 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties. Bridges TM; Brady AE; Kennedy JP; Daniels RN; Miller NR; Kim K; Breininger ML; Gentry PR; Brogan JT; Jones CK; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2008 Oct; 18(20):5439-42. PubMed ID: 18805692 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M Spearing PK; Cho HP; Luscombe VB; Blobaum AL; Boutaud O; Engers DW; Rodriguez AL; Niswender CM; Jeffrey Conn P; Lindsley CW; Bender AM Bioorg Med Chem Lett; 2021 Sep; 47():128193. PubMed ID: 34118412 [TBL] [Abstract][Full Text] [Related]
13. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site. Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor. Davie BJ; Valant C; White JM; Sexton PM; Capuano B; Christopoulos A; Scammells PJ J Med Chem; 2014 Jun; 57(12):5405-18. PubMed ID: 24856614 [TBL] [Abstract][Full Text] [Related]
15. The discovery of VU0486846: steep SAR from a series of M Bertron JL; Cho HP; Garcia-Barrantes PM; Panarese JD; Salovich JM; Nance KD; Engers DW; Rook JM; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW Bioorg Med Chem Lett; 2018 Jul; 28(12):2175-2179. PubMed ID: 29754948 [TBL] [Abstract][Full Text] [Related]
16. High-Throughput Agonist Shift Assay Development for the Analysis of M Homsher MF; Beshore DC; Cassaday J; Squadroni B; Mohammed E; Hartnett M; Day S; Ma L; Pechter D; Smith MD; Monsma F; Zuck P; Finley MF; Uebele VN; Hermes JD SLAS Discov; 2017 Sep; 22(8):1060-1066. PubMed ID: 28426939 [TBL] [Abstract][Full Text] [Related]